3. Lee,P.A., Chernausek,S.D., Hokken-Koelega,A.C., & Czernichow,P. International Small for Gestational Age Advisory Board consensus development conference statement: management of short children born small for gestational age, April 24-October 1, 2001. Pediatrics 111, 1253-1261 (2003)
5. Sas,T., de Waal,W., Mulder,P., Houdijk,M., Jansen,M., Reeser,M., & Hokken-Koelega,A. Growth hormone treatment in children with short stature born small for gestational age: 5-year results of a randomized, double-blind, dose-response trial. J Clin Endocrinol Metab 84, 3064-3070 (1999)
8. de Zegher,F., Albertsson-Wikland,K., Wollmann,H.A., Chatelain,P., Chaussain,J.L., Lofstrom,A., Jonsson,B., & Rosenfeld,R.G. Growth hormone treatment of short children born small for gestational age: growth responses with continuous and discontinuous regimens over 6 years. J Clin Endocrinol Metab 85, 2816-2821 (2000)
18. Johnston,L.B. & Savage,M.O. Should recombinant human growth hormone therapy be used in short small for gestational age children? Arch Dis Child 89, 740-744 (2004)
19. Fjellestad-Paulsen,A., Czernichow,P., Brauner,R., Bost,M., Colle,M., Lebouc,J.Y., Lecornu,M., Leheup,B., Limal,J.M., Raux,M.C., Toublanc,J.E., & Rappaport,R. Three-year data from a comparative study with recombinant human growth hormone in the treatment of short stature in young children with intrauterine growth retardation. Acta Paediatr 87, 511-517 (1998)
20. Fjellestad-Paulsen,A., Simon,D., & Czernichow,P. Short children born small for gestational age and treated with growth hormone for three years have an important catch-down five years after discontinuation of treatment. J Clin Endocrinol Metab 89, 1234-1239 (2004)
21. de Zegher,F., Du Caju,M.V., Heinrichs,C., Maes,M., De Schepper,J., Craen,M., Vanweser,K., Malvaux,P., & Rosenfeld,R.G. Early, discontinuous, high dose growth hormone treatment to normalize height and weight of short children born small for gestational age: results over 6 years. J Clin Endocrinol Metab 84, 1558-1561 (1999)